The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Cervarix



GlaxoSmithKline Biologicals S.A.EU/1/07/419/1-12

Main Information

Trade NameCervarix
Active SubstancesHpv 16 l1 protein
Hpv 18 l1 protein
Dosage FormSuspension for injection
Licence HolderGlaxoSmithKline Biologicals S.A.
Licence NumberEU/1/07/419/1-12

Group Information

ATC CodeJ07BM Papillomavirus vaccines
J07BM02 papillomavirus (human types 16, 18)

Status

License statusAuthorised
Licence Issued20/09/2007
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back